BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Staging
26 results:

  • 1. TNM staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
    Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups.
    Taïeb D; Jha A; Treglia G; Pacak K
    Endocr Relat Cancer; 2019 Nov; 26(11):R627-R652. PubMed ID: 31561209
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Imaging Features of Succinate Dehydrogenase-deficient Pheochromocytoma-Paraganglioma Syndromes.
    Withey SJ; Perrio S; Christodoulou D; Izatt L; Carroll P; Velusamy A; Obholzer R; Lewington V; Jacques AET
    Radiographics; 2019; 39(5):1393-1410. PubMed ID: 31498738
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease?
    Mert I; Kumar A; Torres D; Huang Y; McGree ME; Weaver AL; Cliby WA
    Gynecol Oncol; 2019 May; 153(2):238-241. PubMed ID: 30833135
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel Surgical Strategies in the Treatment of Gynecological Malignancies.
    Angeles MA; Martínez-Gómez C; Migliorelli F; Voglimacci M; Figurelli J; Motton S; Tanguy Le Gac Y; Ferron G; Martinez A
    Curr Treat Options Oncol; 2018 Nov; 19(12):73. PubMed ID: 30411170
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Feral CC; Tissot FS; Tosello L; Fakhry N; Sebag F; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):812-821. PubMed ID: 27900521
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. sdhb mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.
    Assadipour Y; Sadowski SM; Alimchandani M; Quezado M; Steinberg SM; Nilubol N; Patel D; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):230-239. PubMed ID: 27839933
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metastatic pheochromocytoma and paraganglioma.
    Angelousi A; Kassi E; Zografos G; Kaltsas G
    Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 18F-DOPA PET/CT in the evaluation of hereditary sdh-deficiency paraganglioma-pheochromocytoma syndromes.
    Marzola MC; Chondrogiannis S; Grassetto G; Rampin L; Maffione AM; Ferretti A; Opocher G; Schiavi F; Colletti PM; Rubello D
    Clin Nucl Med; 2014 Jan; 39(1):e53-8. PubMed ID: 23856824
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
    Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
    J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
    Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
    Almadrones L
    Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic sdhb-associated pheochromocytoma and paraganglioma.
    Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
    J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tumours of familial origin in the head and neck.
    Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
    Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.
    Fujiwara K; Sakuragi N; Suzuki S; Yoshida N; Maehata K; Nishiya M; Koshida T; Sawai H; Aotani E; Kohno I
    Gynecol Oncol; 2003 Sep; 90(3):637-43. PubMed ID: 13678738
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV.
    Oman M; Blind PJ; Naredi P; Gustavsson B; Hafström LO
    Eur J Surg Oncol; 2001 Aug; 27(5):477-81. PubMed ID: 11504519
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A phase I study of intraperitoneal interferon-alpha 2b and intravenous cis-platinum plus cyclophosphamide chemotherapy in patients with untreated stage III epithelial ovarian cancer: a Gynecologic Oncology Group pilot study.
    Moore DH; Valea F; Walton LA; Soper J; Clarke-Pearson D; Fowler WC
    Gynecol Oncol; 1995 Nov; 59(2):267-72. PubMed ID: 7590485
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.